Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Diana M Bessa de Sousa"'
Autor:
Amber R Philp, Carolina R Reyes, Josselyne Mansilla, Amar Sharma, Chao Zhao, Carlos Valenzuela-Krugmann, Khalil S Rawji, Ginez A Gonzalez Martinez, Penelope Dimas, Bryan Hinrichsen, César Ulloa-Leal, Amie K Waller, Diana M Bessa de Sousa, Maite A Castro, Ludwig Aigner, Pamela Ehrenfeld, Maria Elena Silva, Ilias Kazanis, Cedric Ghevaert, Robin JM Franklin, Francisco J Rivera
Publikováno v:
eLife, Vol 12 (2024)
Revealing unknown cues that regulate oligodendrocyte progenitor cell (OPC) function in remyelination is important to optimise the development of regenerative therapies for multiple sclerosis (MS). Platelets are present in chronic non-remyelinated les
Externí odkaz:
https://doaj.org/article/7461240c98c34149be24d14e2b4bf8cc
Autor:
Diana M. Bessa de Sousa, Ariane Benedetti, Barbara Altendorfer, Heike Mrowetz, Michael S. Unger, Katharina Schallmoser, Ludwig Aigner, Kathrin Maria Kniewallner
Publikováno v:
Aging. 15:630-649
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9662490863e48ec1ad9a88e36a0a6021
https://doi.org/10.18632/aging.204502
https://doi.org/10.18632/aging.204502
Autor:
Kathrin M. Kniewallner, Diana M. Bessa de Sousa, Michael S. Unger, Heike Mrowetz, Ludwig Aigner
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
Alzheimer’s disease (AD) is a neurodegenerative disease with a complex and not fully understood pathogenesis. Besides brain-intrinsic hallmarks such as abnormal deposition of harmful proteins, i.e., amyloid beta in plaques and hyperphosphorylated T
Externí odkaz:
https://doaj.org/article/c3bdc0a3dca64a5896a8cb97e5060cc5
Autor:
Horst Zerbe, Nadine Paiement, Ludwig Aigner, Diana M. Bessa de Sousa, Erick Gonzalez-Labrada, Birgit Hutter-Paier, Rodolphe Obeid, Conway Justin W, Thomas K. Felder, Johanna Michael, Julia Tevini
Publikováno v:
Pharmaceutics
Volume 13
Issue 1
Pharmaceutics, Vol 13, Iss 12, p 12 (2021)
Volume 13
Issue 1
Pharmaceutics, Vol 13, Iss 12, p 12 (2021)
The leukotriene receptor antagonist Montelukast (MTK) is an approved medication for the treatment of asthma and allergic rhinitis. The existing marketed tablet forms of MTK exhibit inconsistent uptake and bioavailability, which partially explains the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21766428a596cc6ec00f450f89678cd
Autor:
Diana M. Bessa de Sousa, Rodolphe Poupardin, Saul A. Villeda, Adam B. Schroer, Thomas Fröhlich, Vanessa Frey, Wolfgang Staffen, Heike Mrowetz, Barbara Altendorfer, Michael S. Unger, Bernhard Iglseder, Bernhard Paulweber, Eugen Trinka, Janne Cadamuro, Martin Drerup, Katharina Schallmoser, Ludwig Aigner, Kathrin M. Kniewallner
Publikováno v:
Frontiers in Molecular Biosciences, Vol 10 (2023)
Introduction: Alzheimer’s disease (AD) and aging are associated with platelet hyperactivity. However, the mechanisms underlying abnormal platelet function in AD and aging are yet poorly understood.Methods: To explore the molecular profile of AD and
Externí odkaz:
https://doaj.org/article/636238625d2e475984b6becd06a2383c